PLK2 and breast cancer: To gain more insight into the CNAs in different breast cancer subtypes, we performed GISTIC analysis on TCGA breast tumors and discovered that the loss of PLK2 was identified in 21.8% of all patients with breast cancer (Fig. 1B).